Why the study?
Diagnosing and managing cardiac arrhythmias like tachy-brady syndrome in patients with paranoid and catatonic schizophrenia is challenging due to unshared symptoms and psychotropic drug effects.
Case Report (n=1)
A dual-chamber pacemaker combined with beta-blocker therapy successfully managed tachy-brady syndrome in a patient with severe schizophrenia and catatonia.
Answers are grounded in this paper and cite their sources.
May support combined pacing and beta-blockade in tachy-brady syndrome with schizophrenia; leaves open confirmation in controlled studies.
Tachy-brady syndrome is the result of sinus node dysfunction (SND), an electrocardiographic phenomenon caused by defective pacemaker functioning that leads to alternating arrhythmias. We present a case of a 73-year-old male with multiple mental health and medical comorbidities who was admitted to the inpatient floor for catatonia, paranoid delusions, refusal to eat, inability to cooperate with activities of daily life, and generalized weakness. Upon admission, a 12-lead electrocardiogram (ECG) showed an episode of atrial fibrillation with a ventricular rate of 64 beats per minute (bpm). During hospitalization, telemetry recorded a variety of arrhythmias such as ventricular bigeminy, atrial fibrillation, supraventricular tachycardia (SVT), multifocal atrial contractions, and sinus bradycardia. Each episode spontaneously reverted and the patient remained asymptomatic throughout these arrhythmic changes. These frequently fluctuating arrhythmias on resting ECG confirmed the diagnosis of tachycardia-bradycardia syndrome, also known as tachy-brady syndrome. Medical intervention, especially for cardiac arrhythmias, in patients with paranoid and catatonic schizophrenia can be challenging, as they might not share their symptoms. Additionally, certain psychotropic medications can also cause cardiac arrhythmias and must be carefully evaluated. The decision was made to start the patient on a beta-blocker and direct oral anticoagulation for reducing the risk of thromboembolic events. Due to an unsatisfactory response to drug therapy alone, the patient qualified as a candidate for definitive treatment with an implantable dual-chamber pacemaker. Our patient had a dual-chamber pacemaker implanted to prevent bradyarrhythmias and continued oral beta-blockers to prevent tachyarrhythmias.
No takes yet. Share an insight, caveat, or question.
Knight et al. (2023) conducted a case report in Tachy-brady syndrome, schizophrenia (n=1). Dual-chamber pacemaker and metoprolol was evaluated on Control of alternating bradycardia and tachycardia.
Synapse has enriched 10 related papers. Consider them for comparative context: